New eye injection for Diabetes-Related vision loss enters safety testing
Disease control
Not yet recruiting
This early-stage study tests whether a single eye injection of PRO-169 is safe for people with diabetic macular edema, a condition that causes vision loss in diabetes. The main focus is checking if the body makes antibodies against the drug, which could reduce its effectiveness. …
Phase: PHASE1 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Disease control
Last updated May 17, 2026 08:53 UTC